Breaks Categories: Stock Spotlights

TuesdayNov 02, 2021 2:35 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Targeting Development of Innovative Insurtech, Fintech Products for Customers

FingerMotion (OTCQX: FNGR) launched its youngest operational division, Sapientus, in mid-2020 following years of R&D work. “In the past few years, we’ve had our inhouse team of actuaries and data scientists, who really know the ins and outs of the insurance industry, and what they’ve been doing is they’ve been deciphering information from all these different sources and putting in the risk metrics that could provide those fresh insights and intelligence for the insurance field,” a recent article quotes FingerMotion CEO Martin Shen as saying. “FingerMotion believes that by integrating its Sapientus data blocks with external data sources such as…

Continue Reading

MondayNov 01, 2021 12:51 pm

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on Target to Become House of Brands, Great Channel Partner

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently welcomed former U.S. Congressman and now public policy consultant Ryan Costello to its board of directors. Costello is expected to deepen RWB’s U.S.-based representation, which is key as federal policy on cannabis shifts. The company also announced that it has built a new production facility to good manufacturing practice (“GMP”) specifications in Florida as part of an effort to capitalize on the growing cannabis derivative market there. The Florida facility is built to accommodate the demand for edibles. “Red White & Bloom has built a branded capsule and rosin line…

Continue Reading

MondayNov 01, 2021 11:42 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Way Through Unique Psychedelic Drug Development Focus

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is nearing the launch of a phase 2a clinical trial that aims to establish the value of its psychedelic drug candidate, TRP-8802, in treating chronic and severe eating disorders such as Prader-Willi Syndrome (“PWS”), hypothalamic obesity disorder resulting from the removal of a brain tumor, and binge eating dysfunction. Tryp also plans to execute phase 2b clinical trials for its proprietary psychedelic candidate TRP-8803 to evaluate its ability to penetrate the natural blood-brain barrier and effectively alleviate pain and addiction concerns, including targets for phantom limb pain and fibromyalgia. “Tryp’s product development moves beyond…

Continue Reading

MondayNov 01, 2021 11:26 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Shines the Spotlight on Vegan Products, Industry Trends and Innovators

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital hub of a thriving plant-based market ecosystem, produces a vodcast series offering weekly insights into vegan products, industry trends and athletes who thrive on a plant-based diet. Through its YouTube channel, the company provides upbeat how-to videos for recipes and fitness practices, as well as news about the state of the industry and PlantX’s investor relations. In addition, PlantX’s blog provides the mortar for binding its community of vegan lifestyle interests together with education to make beneficial habits more accessible. “Over the last 10 years I’ve learned that a…

Continue Reading

FridayOct 29, 2021 2:19 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Inching Closer to a World with Sustainable, Clean Fossil Fuel Replacement

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has achieved several milestones and made strategic investments that bring it even closer to its ultimate goal of providing sustainable, clean energy to reduce carbon emissions. The company, which is pushing for the change from fossil fuels, has appointed André Mech, who will lend his years of experience to the strategic carbon credit and emissions reduction specialist position, helping FuelPositive sell its carbon credits in the same way Tesla does. With the hydrogen economy being at the core of the company’s agenda, FuelPositive is spearheading the modular and scalable carbon-free ammonia industry. “To date, FuelPositive…

Continue Reading

FridayOct 29, 2021 2:10 pm

NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Eyes Expansion, Stands to Benefit from Recently Signed AB45

Green Hygienics Holdings (OTCQB: GRYN), an enterprise focused on the high-standard cultivation and processing of industrial hemp, is one company expected to gain from the newly signed Assembly Bill 45 (“AB45”), which is set to benefit companies that grow and produce industrial hemp. AB45 allows for hemp-derived cannabinoids, extracts and derivatives in food and dietary supplements. “The company grows its hemp in a controlled environment at its farm in California, which, with 824 acres and 392,000 square feet of greenhouse space, is the largest USDA Certified Organic Hemp for CBD farm in North America,” reads a recent article. “The company…

Continue Reading

FridayOct 29, 2021 1:59 pm

NetworkNewsBreaks – Hero Technologies Inc. (HENC) Continues to Position Itself as Multistate Operator in Cannabis Sector

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license…

Continue Reading

FridayOct 29, 2021 1:42 pm

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leveraging CDA Technology for Critical Early Cancer Detection

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, since 2015 has commercially proven out its concepts through the development and sale of its cancer detection technology, Cancer Differentiation Analysis (“CDA”) for early detection of pre-cancerous disease and cancer. “The company has published numerous reports of clinical study results at major conferences, including ACSO conferences, and has been awarded over 100 patents globally. AnPac Bio is now able to make the claim that it is saving lives on a daily basis by detecting 26 different types of cancer very early, through the tens of…

Continue Reading

FridayOct 29, 2021 1:08 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Earns Coverage for DehydraTECH(TM)’s Potential Market Reach, Multiple Uses

Lexaria Bioscience Corp. (NASDAQ: LEXX) was recently part of coverage by Zacks Small-Cap Research analysts based on its market potential. Zacks, which focuses its coverage on small and micro-cap companies it regards as under-followed or under-valued by the broader market in an effort to benefit investors as well as worthy innovators, valued the company at $15 per share. The valuation was based on the company’s portfolio supporting Lexaria’s patented DehydraTECH(TM) consumption and the multiple potential uses of the technology. The technology is also relatively low-cost, with the capacity to produce up to 400,000 consumer packaged goods through existing manufacturer relationships.…

Continue Reading

ThursdayOct 28, 2021 12:01 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Stands Distinct in Patient Support

Nemaura Medical (NASDAQ: NMRD), a company focused on providing digital and glucose monitoring solutions for patients dealing with diabetes, pays close attention to essential information and research that impacts the successful implementation of its solutions. Recently, the company tweeted about a study published by Dove Medical Press that included a survey of 105 participants with type 2 diabetes. The report indicated that most participants were interested in using electronic methods to communicate more with their doctors between visits. “These findings are particularly interesting to Nemaura, which has developed a proprietary technology that replaces traditional invasive methods of glucose monitoring that…

Continue Reading